These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Polymyalgia rheumatica and giant cell arteritis. Ettlinger RE; Hunder GG; Ward LE Annu Rev Med; 1978; 29():15-22. PubMed ID: 348031 [No Abstract] [Full Text] [Related]
43. [Giant-cell arteritis. Comments on the case histories of 30 patients]. Airoldi M; Fantasia R; Cotti D; Castiglioni G; Pelucco L Recenti Prog Med; 1994 Oct; 85(10):485-9. PubMed ID: 7809462 [TBL] [Abstract][Full Text] [Related]
44. An Older Adult with Headache and Visual Blurring. Cottrell DB; Welch EC J Emerg Nurs; 2016 Jul; 42(4):348-9. PubMed ID: 26953513 [No Abstract] [Full Text] [Related]
45. Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Breuer GS; Nesher R; Nesher G Clin Exp Rheumatol; 2008; 26(6):1103-6. PubMed ID: 19210879 [TBL] [Abstract][Full Text] [Related]
46. Selective temporal arteriography and biopsy in giant cell arteritis: polymyalgia rheumatica. Moncada R; Baker D; Rubinstein H; Shah D; Love L Am J Roentgenol Radium Ther Nucl Med; 1974 Nov; 122(3):580-5. PubMed ID: 4432981 [No Abstract] [Full Text] [Related]
47. Giant cell arteritis presenting with hemianopic visual field loss. Randhawa S; Van Stavern GP Can J Ophthalmol; 2007 Jun; 42(3):486-7. PubMed ID: 17508057 [No Abstract] [Full Text] [Related]
48. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Font C; Cid MC; Coll-Vinent B; López-Soto A; Grau JM Br J Rheumatol; 1997 Feb; 36(2):251-4. PubMed ID: 9133940 [TBL] [Abstract][Full Text] [Related]
49. Polymyalgia rheumatica and temporal arthritis. Epperly TD; Moore KE; Harrover JD Am Fam Physician; 2000 Aug; 62(4):789-96, 801. PubMed ID: 10969858 [TBL] [Abstract][Full Text] [Related]
50. Giant cell arteritis with polymyalgia rheumatica, loss of vision, and abdominal symptoms occurring during a four year course. Simkin PA; Healey LA Arthritis Rheum; 1969 Apr; 12(2):147-51. PubMed ID: 5777770 [No Abstract] [Full Text] [Related]
51. Assessment and management of polymyalgia rheumatica in older adults. Kennedy-Malone LM; Enevold GL Geriatr Nurs; 2001; 22(3):152-5; quiz 155. PubMed ID: 11410767 [TBL] [Abstract][Full Text] [Related]
52. [Giant cell arteritis. Multicenter study of 100 cases with positive biopsies]. Bella Cueto F; Costa Roma J; González de Zárate P; Pujol Farriol R; Aguirre Errasti L; Martínez L de Letona J Med Clin (Barc); 1985 Jun; 85(2):43-8. PubMed ID: 4021613 [No Abstract] [Full Text] [Related]
53. Ocular manifestations of giant cell arteritis. Hayreh SS; Podhajsky PA; Zimmerman B Am J Ophthalmol; 1998 Apr; 125(4):509-20. PubMed ID: 9559737 [TBL] [Abstract][Full Text] [Related]
54. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589 [TBL] [Abstract][Full Text] [Related]
55. [An atypical case of Horton's arteritis and associated polymyalgia rheumatica]. Botrugno A; Rebba A; Pasinetti S; Colombi R; Dolci C; Alari G Minerva Med; 1998 May; 89(5):177-9. PubMed ID: 9676184 [TBL] [Abstract][Full Text] [Related]
56. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Rodriguez-Valverde V; Sarabia JM; González-Gay MA; Figueroa M; Armona J; Blanco R; Fernández-Sueiro JL; Martínez-Taboada VM Am J Med; 1997 Apr; 102(4):331-6. PubMed ID: 9217613 [TBL] [Abstract][Full Text] [Related]
57. Sensitivity of clinically abnormal temporal artery in giant cell arteritis. Zenone T; Puget M Int J Rheum Dis; 2013 Dec; 16(6):771-3. PubMed ID: 24382287 [No Abstract] [Full Text] [Related]